eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Forest Laboratories UK Limited

Riverbridge House, Anchor Boulevard, Crossways Business Park, Dartford, Kent, DA2 6SL
Telephone: +44 (0)1322 421 800
Fax: +44 (0)1322 291 306
WWW: http://www.forestlabs.com
Medical Information e-mail: medinfo@forest-labs.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 27/04/2012
SPC Venos Expectorant


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Beecham's Veno's Expectorant

Veno's Expectorant


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Guaifenesin BP 100mg, Liquid Glucose BPC (1963) 3.0g, Treacle 1.35g


Go to top of the page
3. PHARMACEUTICAL FORM

Oral Solution


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

An expectorant for the symptomatic relief of coughs (including bronchial cough) and chesty catarrh, particularly associated with colds and flu.

The product also has a soothing, protective, demulcent action on a sore, irritated, tickling and inflamed throat.


Go to top of the page
4.2 Posology and method of administration

Adults and children over the age of 12: Take one 10ml dose (two 5ml spoonfuls) and repeat every 2 to 3 hours.

Route of Administration

Oral


Go to top of the page
4.3 Contraindications

Known hypersensitivity to guaifenesin, treacle, glucose or to any of the excipients.


Go to top of the page
4.4 Special warnings and precautions for use

Patients suffering from chronic cough or asthma should consult a physician before taking this product.

Patients should stop using the product and consult a health care professional if cough lasts for more than 5 days or comes back, or is accompanied by a fever, rash or persistent headache.

Do not take with a cough suppressant.

Special Label Warnings

Keep out of the reach and sight of children.

If symptoms persist, consult your doctor.

Do not exceed the stated dose.

Do not use with other cough and cold medicines.

Contains 6.68g total sugars per 10ml dose. This should be taken into account in patients with diabetes mellitus.

Patients with rare glucose-galactose malabsorption should not take this medicine.

Contains 9.6mg sodium per 10ml dose. This should be taken into consideration in patients on a controlled sodium diet.

Contains sodium benzoate and sodium metabisulphite, which may rarely cause severe allergic reactions and bronchospasm.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None


Go to top of the page
4.6 Pregnancy and lactation

Use in pregnancy and lactation is not contraindicated. However, as with all medicines, caution should be exercised during pregnancy and lactation.


Go to top of the page
4.7 Effects on ability to drive and use machines

None


Go to top of the page
4.8 Undesirable effects

Immune system disorders:

Unknown: allergic reactions, angioedema, anaphylactic reactions

Respiratory, thoracic and mediastinal disorders:

Unknown: Dyspnoea (in association with other symptoms of hypersensitivity)

Skin and subcutaneous disorders:

Unknown: Rash, urticaria

Gastrointestinal disorders:

Unknown: nausea, vomiting, abdominal discomfort


Go to top of the page
4.9 Overdose

Very large doses of guaifenesin cause nausea and vomiting. Vomiting would be treated by fluid replacement and monitoring of electrolytes if indicated.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Guaifenesin is an expectorant.

Treacle and Liquid Glucose are demulcents.


Go to top of the page
5.2 Pharmacokinetic properties

None Stated


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of any relevance additional to that already included in other sections of the SPC.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Macrogol

Glacial acetic acid

Sodium benzoate (E211)

Capsicum tincture

Sodium metabisulphite (E223)

Aniseed oil

Xanthan gum

Levomenthol

Camphor

Sodium cyclamate

Acesulfame potassium

Liquorice aniseed flavour

Caramel colour (E150)


Go to top of the page
6.2 Incompatibilities

None


Go to top of the page
6.3 Shelf life

Unopened: Three years

Opened: Six months


Go to top of the page
6.4 Special precautions for storage

None


Go to top of the page
6.5 Nature and contents of container

Amber cylindrical glass bottle fitted with a child resistant and tamper evident plastic screw cap.

Pack size: 100 or 160ml.


Go to top of the page
6.6 Special precautions for disposal and other handling

None


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Forest Laboratories UK Limited

Riverbridge House

Anchor Boulevard

Crossways Business Park

Dartford

Kent

DA2 6SL

U.K.


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00108/0338


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

31/01/1983 / 06/09/2004


Go to top of the page
10. DATE OF REVISION OF THE TEXT

April 2012



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/21631/SPC/


Active Ingredients/Generics

 
   guaifenesin
   glucose, liquid
   treacle